These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34968420)

  • 1. Morphological profiling by means of the Cell Painting assay enables identification of tubulin-targeting compounds.
    Akbarzadeh M; Deipenwisch I; Schoelermann B; Pahl A; Sievers S; Ziegler S; Waldmann H
    Cell Chem Biol; 2022 Jun; 29(6):1053-1064.e3. PubMed ID: 34968420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubulin is a molecular target of the Wnt-activating chemical probe.
    Fukuda Y; Sano O; Kazetani K; Yamamoto K; Iwata H; Matsui J
    BMC Biochem; 2016 May; 17(1):9. PubMed ID: 27207629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel microtubule inhibitors effective in fission yeast and human cells and their effects on breast cancer cell lines.
    Morishita J; Nurse P
    Open Biol; 2021 Sep; 11(9):210161. PubMed ID: 34493069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multipronged Approach Establishes Covalent Modification of β-Tubulin as the Mode of Action of Benzamide Anti-cancer Toxins.
    Povedano JM; Rallabandi R; Bai X; Ye X; Liou J; Chen H; Kim J; Xie Y; Posner B; Rice L; De Brabander JK; McFadden DG
    J Med Chem; 2020 Nov; 63(22):14054-14066. PubMed ID: 33180487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward Discovery of Novel Microtubule Targeting Agents: A SNAP-tag-Based High-Content Screening Assay for the Analysis of Microtubule Dynamics and Cell Cycle Progression.
    Berges N; Arens K; Kreusch V; Fischer R; Di Fiore S
    SLAS Discov; 2017 Apr; 22(4):387-398. PubMed ID: 28328318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent.
    Jost M; Chen Y; Gilbert LA; Horlbeck MA; Krenning L; Menchon G; Rai A; Cho MY; Stern JJ; Prota AE; Kampmann M; Akhmanova A; Steinmetz MO; Tanenbaum ME; Weissman JS
    Mol Cell; 2017 Oct; 68(1):210-223.e6. PubMed ID: 28985505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.
    Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO
    J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective targeting of tumorigenic cancer cell lines by microtubule inhibitors.
    Abdullah NM; Rosania GR; Shedden K
    PLoS One; 2009; 4(2):e4470. PubMed ID: 19214225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel and potent small-molecule inhibitors of tubulin with antitumor activities by virtual screening and biological evaluations.
    Liu G; Jiao Y; Huang C; Chang P
    J Comput Aided Mol Des; 2019 Jul; 33(7):659-664. PubMed ID: 31165955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site.
    Matthew S; Chen QY; Ratnayake R; Fermaintt CS; Lucena-Agell D; Bonato F; Prota AE; Lim ST; Wang X; Díaz JF; Risinger AL; Paul VJ; Oliva MÁ; Luesch H
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tivantinib (ARQ 197) exhibits antitumor activity by directly interacting with tubulin and overcomes ABC transporter-mediated drug resistance.
    Aoyama A; Katayama R; Oh-Hara T; Sato S; Okuno Y; Fujita N
    Mol Cancer Ther; 2014 Dec; 13(12):2978-90. PubMed ID: 25313010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of microtubule stabilizers with novel scaffold structures based on virtual screening, biological evaluation, and molecular dynamics simulation.
    Mao J; Luo QQ; Zhang HR; Zheng XH; Shen C; Qi HZ; Hu ML; Zhang H
    Chem Biol Interact; 2022 Jan; 352():109784. PubMed ID: 34932952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubulin inhibitor identification by bioactive conformation alignment pharmacophore-guided virtual screening.
    Nagarajan S; Choi MJ; Cho YS; Min SJ; Keum G; Kim SJ; Lee CS; Pae AN
    Chem Biol Drug Des; 2015 Nov; 86(5):998-1016. PubMed ID: 25845798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.
    Tangutur AD; Kumar D; Krishna KV; Kantevari S
    Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What tubulin drugs tell us about microtubule structure and dynamics.
    Amos LA
    Semin Cell Dev Biol; 2011 Dec; 22(9):916-26. PubMed ID: 22001382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones.
    Aryapour H; Riazi GH; Ahmadian S; Foroumadi A; Mahdavi M; Emami S
    Pharm Biol; 2012 Dec; 50(12):1551-60. PubMed ID: 22984888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin.
    Sun K; Sun Z; Zhao F; Shan G; Meng Q
    Future Med Chem; 2021 May; 13(9):839-858. PubMed ID: 33821673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
    Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
    Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of action of microtubule-stabilizing anticancer agents.
    Prota AE; Bargsten K; Zurwerra D; Field JJ; Díaz JF; Altmann KH; Steinmetz MO
    Science; 2013 Feb; 339(6119):587-90. PubMed ID: 23287720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.